BioVU
-
August 11, 2022
Genotype-specific blood counts
Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts. -
June 29, 2022
Study shows genotype leads to discontinued, decreased medication
-
June 16, 2022
BMI genetics influence heart function
Vanderbilt researchers have discovered that a genetic predisposition to elevated body mass index increases the risk of diastolic dysfunction — a cardiac condition that can lead to heart failure. -
June 8, 2022
BioVU celebrates 15 years supporting personalized medicine
BioVU is celebrating its 15th year and has enabled hundreds of studies and publications exploring the genetic underpinnings of a host of conditions including cancer, heart disease and diabetes. -
May 19, 2022
Genetics and blood pressure
Including polygenic risk scores for blood pressure may improve predictive models to identify people at risk for treatment-resistant hypertension. -
May 19, 2022
A clue to an adverse drug event in children
Considering metabolic (CYP2D6) enzyme activity score and patient age may aid in determining an individual’s risk for an adverse event with administration of the anti-arrhythmic drug propafenone. -
May 9, 2022
Gene variants and transplant drug dose
Genotyping multiple enzymes that metabolize the immunosuppressive drug tacrolimus — common used for lung transplant recipients — is important for correct dosing of the drug, Vanderbilt researchers found.